Meningococcal polysaccharide vaccine group W-135

DB13887

biotech approved experimental investigational

Deskripsi

Meningococcal group W-135 polysaccharide is group-specific polysaccharide antigens extracted and purified from *Neisseria meningitidis* serogroup W-135. *N. meningitidis* is a bacteria that causes endemic and epidemic diseases including meningitis and meningococcemia. It is subcutaneously administered as an active immunization against the invasive meningococcal disease caused by the serogroup W-135.

Struktur Molekul 2D

Struktur tidak tersedia

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Obat

0 Data
Tidak ada data.

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 12 • International brands: 0
Produk
  • Menomune - A/c/y/w-135 Combined
    Injection; Kit • - • Subcutaneous • US • Approved
  • Menomune-A/c/y/w-135
    Powder, for solution • - • Subcutaneous • Canada • Approved
  • Menomune-A/c/y/w-135
    Kit; Powder, for solution • - • Subcutaneous • Canada • Approved
  • Menomune-A/c/y/w-135
    Powder, for solution • - • Subcutaneous • Canada • Approved
  • Menquadfi
    Injection, solution • - • Intramuscular • EU • Approved
  • Menquadfi
    Injection, solution • - • Intramuscular • EU • Approved
  • Menquadfi
    Injection, solution • - • Intramuscular • EU • Approved
  • Menquadfi
    Injection, solution • - • Intramuscular • EU • Approved
Menampilkan 8 dari 12 produk.

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul